Lyrica 75 MG capsule 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F1U14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,154
Award facts
- Contract value 100% obligated
- $4,154.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,154.30 to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to the vendor. Performance will be executed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Lyrica (pregabalin) is a neurological treatment commonly used to manage neuropathic pain and other conditions requiring pharmaceutical intervention. As a subsidiary of Cencora, Inc., AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The broader IDC contract encompasses a comprehensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, enabling the company to fulfill essential pharmaceutical needs for Defense Health Agency facilities and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F1U14?
SPE2DR26F1U14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F1U14 worth?
The government has obligated $4,154 on SPE2DR26F1U14.
Is contract SPE2DR26F1U14 an order under another contract?
Yes. SPE2DR26F1U14 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U14 competed?
The extent of competition for SPE2DR26F1U14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award